EUVIMEDEUVIMED entdecken
Crossref

Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas

G F Foppele, M Fiocco, J F Ubbels, L B Been, J J de Haan, D A X Schinagl, H Bonenkamp, I M E Desar, A N Scholten, W J van Houdt, L Heimans, H H Hartgrink und 4 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von G F Foppele und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Netherlands Cancer Institute, the Netherlands; Department of Radiotherapy, Leiden University Medical Centre, the Netherla…. Hauptthemen laut MEDLINE: Sarcoma, Radiation Dose Hypofractionation, COVID-19, Soft Tissue Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Forestry and Grassland Administration, Sarcoma Foundation of America, Dutch Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Moderate hypofractionation was adopted to reduce hospital visits during the COVID-19 pandemic aiming to maintain treatment efficacy for soft tissue sarcoma (STS) patients, shifting preoperative schedules from 25 fractions of 2 Gy to 14-15 fractions of 3 Gy. This study evaluates the clinical implications and outcomes of this schedule, focusing on wound complications, radiation toxicity, local tumour control, and distant metastases. PATIENTS AND METHODS: Data was collected from patients treated between 01 and 01-2020 and 31-12-2023. Outcomes included wound complications within 120 days post-surgery, local-recurrence, distant metastases and radiation toxicity. Logistic regression was performed to identify factors associated with wound complications. The cumulative incidence of local recurrence and distant metastases were estimated with a competing risk model. RESULTS: Sixty-six patients were analysed, with a mean age of 74 years (standard deviation (SD)± 11). Tumours were mainly localized in the lower extremities (64 %), mean size 103 mm (SD±58). Median follow-up was 29 months (range 2-50). A R0 resection margin was achieved in 77 % of the operated patients. The wound complication rate was 33 %, with moderate complications in 13 patients and severe in 6. The cumulative incidences of local recurrence and distant metastases at 2 years were 7.6 % (standard error (SE) 3.7 %) and 29 % (SE 6 %, Fig. 1) respectively. Acute grade 3 dermatitis occurred in one patient (1.5 %)and two patients experienced late grade 3 toxicity (fractures, 3.0 %). Twenty patients developed distant metastases, two diagnosed before start of the treatment. Eighteen patients died, with six deaths from distant metastases and one from the primary tumour. CONCLUSION: Preoperative moderate hypofractionation for STS during COVID-19 showed promising results, with no increase in postoperative wound complications and favourable local failure rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaRadiation Dose HypofractionationCOVID-19Soft Tissue NeoplasmsHumansMaleFemaleAgedMiddle AgedAged, 80 and overNeoplasm Recurrence, LocalRetrospective StudiesSARS-CoV-2Treatment OutcomeRadiation Injuries

Stichwörter der Autor:innen

COVID-19 PandemicDistant MetastasesLocal RecurrenceModerate hypofractionationPreoperative radiotherapyRadiation ToxicitySoft tissue sarcoma (STS)Treatment OutcomesWound complications

Autor:innen und Institutionen

  • Department of Radiotherapy, Netherlands Cancer Institute, the Netherlands; Department of Radiotherapy, Leiden University Medical Centre, the Netherlands.
  • Mathematical Institute, University of Leiden, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, the Netherlands; Princess Máxima Centre for Paediatric Oncology, Utrecht, the Neth…
  • Department of Radiotherapy, University Medical Centre Groningen, the Netherlands.
  • Department of Surgery, University Medical Centre Groningen, the Netherlands.
  • Department of Medical Oncology, University Medical Centre Groningen, the Netherlands.
  • Department of Radiotherapy, Radboud University Medical Centre Nijmegen, the Netherlands.

Förderung

  • National Forestry and Grassland Administration
  • Sarcoma Foundation of America
  • Dutch Cancer Society

Zitieren

APA

Foppele, G. F., Fiocco, M., Ubbels, J. F., Been, L. B., de Haan, J. J., Schinagl, D. A. X., Bonenkamp, H., Desar, I. M. E., Scholten, A. N., van Houdt, W. J., Heimans, L., Hartgrink, H. H., Gelderblom, H., van Hezewijk, M., Haas, R. L. M., & Wiltink, L. M. (2025). Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115234

Vancouver

Foppele GF, Fiocco M, Ubbels JF, Been LB, de Haan JJ, Schinagl DAX, et al. Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115234

BibTeX
@article{Foppele2025,
  author = {Foppele, G F and Fiocco, M and Ubbels, J F and Been, L B and de Haan, J J and Schinagl, D A X and Bonenkamp, H and Desar, I M E and Scholten, A N and van Houdt, W J and Heimans, L and Hartgrink, H H and Gelderblom, H and van Hezewijk, M and Haas, R L M and Wiltink, L M},
  title = {Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115234}
}
Kostenlos starten →